Portal de investigación
Epigenetic inactivation of the p53-induced long noncoding RNA TP53 target 1 in human cancer
Autores de IIS La Fe
Participantes ajenos a IIS La Fe
- Diaz-Lagares A
- Crujeiras AB
- Lopez-Serra P
- Soler M
- Setien F
- Goyal A
- Hashimoto Y
- Martinez-Cardús A
- Gomez A
- Heyn H
- Moutinho C
- Espada J
- Vidal A
- Paúles M
- Galán M
- Sala N
- Akiyama Y
- Martínez-Iniesta M
- Farré L
- Villanueva A
- Gross M
- Diederichs S
- Guil S
- Esteller M
Grupos
Abstract
Long noncoding RNAs (lncRNAs) are important regulators of cellular homeostasis. However, their contribution to the cancer phenotype still needs to be established. Herein, we have identified a p53-induced lncRNA, TP53TG1, that undergoes cancer-specific promoter hypermethylation-associated silencing. In vitro and in vivo assays identify a tumor-suppressor activity for TP53TG1 and a role in the p53 response to DNA damage. Importantly, we show that TP53TG1 binds to the multifaceted DNA/RNA binding protein YBX1 to prevent its nuclear localization and thus the YBX1-mediated activation of oncogenes. TP53TG1 epigenetic inactivation in cancer cells releases the transcriptional repression of YBX1-targeted growth-promoting genes and creates a chemoresistant tumor. TP53TG1 hypermethylation in primary tumors is shown to be associated with poor outcome. The epigenetic loss of TP53TG1 therefore represents an altered event in an lncRNA that is linked to classical tumoral pathways, such as p53 signaling, but is also connected to regulatory networks of the cancer cell.
Datos de la publicación
- ISSN/ISSNe:
- 0027-8424, 1091-6490
- Tipo:
- Article
- Páginas:
- 7535-7544
- PubMed:
- 27821766
- Factor de Impacto:
- 6,576 SCImago ℠
- Cuartil:
- Q1 SCImago ℠
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA NATL ACAD SCIENCES
Citas Recibidas en Web of Science: 117
Documentos
- No hay documentos
Filiaciones
Keywords
- DNA methylation; long noncoding RNA; epigenetics; cancer
Proyectos y Estudios Clínicos
RED TEMATICA DE INVESTIGACION COOPERATIVA EN CANCER (RTICC)
Investigador Principal: MIGUEL ÁNGEL SANZ ALONSO
RD12/0036/0014 . INSTITUTO DE SALUD CARLOS III . 2013
INTEGRATIVE (EPI)GENOMIC AND DRUG TARGET ANALYSIS FOR IDENTIFICATION/VALIDATION OF CLINICALLY VALUABLE BIOMARKERS TO IMPROVE THE POOR OUTCOME OF NON-SMALL CELL LUNG CANCER PATIENTS.
Investigador Principal: JUAN SANDOVAL DEL AMOR
CP13/00055 . INSTITUTO DE SALUD CARLOS III; FUNDACIÓN PARA LA INVESTIGACIÓN DEL HOSPITAL UNIVERSITARIO LA FE DE LA COMUNIDAD VALENCIANA . 2015
ADQUISICIÓN DE UNA PLATAFORMA BIG DATA PARA EL ANÁLISIS Y LA GESTIÓN DE DATOS MULTI-ÓMICOS Y CLÍNICOS ORIENTADA A LA MEDICINA DE PRECISIÓN.
Investigador Principal: JOSÉ VICENTE CASTELL RIPOLL
FUFE15-EE-3906 . MINISTERIO DE ECONOMIA Y COMPETITIVIDAD . 2016
IMPLANTACIÓN DE LA MEDICINA PERSONALIZADA EN ONCOLOGÍA PEDIÁTRICA: FARMACOGENÉTICA, EPIGENÉTICA, METABOLÓMICA Y LOS SISTEMAS DE INFORMACIÓN.
Investigador Principal: MARÍA JOSÉ HERRERO CERVERA
MJH-CIS-2016-01 . FUNDACION MUTUA MADRILEÑA . 2016
Cita
Diaz A,Crujeiras AB,Lopez P,Soler M,Setien F,Goyal A,SANDOVAL J,Hashimoto Y,Martinez A,Gomez A,Heyn H,Moutinho C,Espada J,Vidal A,Paúles M,Galán M,Sala N,Akiyama Y,Martínez M,Farré L,Villanueva A,Gross M,Diederichs S,Guil S,Esteller M. Epigenetic inactivation of the p53-induced long noncoding RNA TP53 target 1 in human cancer. Proc Natl Acad Sci U S A. 2016. 113. (47):p. 7535-7544. IF:9,661. (1).